Last update 25 May 2025

Radiprodil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NP 121, RGH-896, UCB-3491
Target
Action
antagonists
Mechanism
GluN2B antagonists(Glutamate [NMDA] receptor subunit epsilon 2 antagonists)
Active Organization
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationBreakthrough Therapy (United States), Orphan Drug (United States), PRIME (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC21H20FN3O4
InChIKeyGKGRZLGAQZPEHO-UHFFFAOYSA-N
CAS Registry496054-87-6

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SeizuresPhase 2
Australia
10 Jul 2024
SeizuresPhase 2
Belgium
10 Jul 2024
SeizuresPhase 2
Canada
10 Jul 2024
SeizuresPhase 2
Italy
10 Jul 2024
SeizuresPhase 2
Netherlands
10 Jul 2024
SeizuresPhase 2
Poland
10 Jul 2024
SeizuresPhase 2
Spain
10 Jul 2024
SeizuresPhase 2
United Kingdom
10 Jul 2024
Spasms, InfantilePhase 2
France
04 Dec 2017
Diabetic peripheral neuropathic painPhase 2
United States
01 Feb 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
10
daautunijr(crlgfapkjb) = wbojfmoyrq rqqrqbqyjg (hmhxzlnjfj )
-
01 Feb 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free